In a different recent study, significantly increased saliva levels of anti-inflammatory oxytocin and pro-inflammatory IL-1β were detected in the saliva of migraine patients treated before and after VNS treatment, while obesity was present in only 30% of the cohort [52]. This evidence concerns the gene IL1B and migraine disorder.